Health Care & Life Sciences » Biotechnology | Minerva Neurosciences Inc.

Minerva Neurosciences Inc.

Minerva Neurosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.38
Market Cap
$266.15 M
Shares Outstanding
39.03 M
Public Float
31.4 M

Profile

Address
1601 Trapelo Road
Waltham Massachusetts 02451
United States
Employees -
Website http://www.minervaneurosciences.com
Updated 07/08/2019
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. Its product portfolio includes MIN-101, MIN-117, MIN-202 and MIN-301. The company was founded by Rogerio Vivaldi Coelho on April 23, 2007 and is headquartered in Cambridge, MA.

Financials

View All

Rémy Luthringer
Executive Chairman & Chief Executive Officer
Jeryl L. Hilleman
Director